{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T08:41:36Z","timestamp":1790066496303,"version":"4.0.1"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,12,20]],"date-time":"2018-12-20T00:00:00Z","timestamp":1545264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"DOI":"10.3389\/fimmu.2018.03035","type":"journal-article","created":{"date-parts":[[2018,12,20]],"date-time":"2018-12-20T02:59:13Z","timestamp":1545274753000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":62,"title":["Antigen-Specific IgG Subclasses in Primary and Malignancy-Associated Membranous Nephropathy"],"prefix":"10.3389","volume":"9","author":[{"given":"Franziska","family":"von Haxthausen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Reinhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans O.","family":"Pinnschmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Rink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Soave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elion","family":"Hoxha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf A. K.","family":"Stahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,12,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa0810457","article-title":"M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy","volume":"361","author":"Beck","year":"2009","journal-title":"N Engl J Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1056\/NEJMoa1409354","article-title":"Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy","volume":"371","author":"Tomas","year":"2014","journal-title":"N Engl J Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1056\/NEJM199307083290203","article-title":"Prognosis of untreated patients with idiopathic membranous nephropathy","volume":"329","author":"Schiepatti","year":"1993","journal-title":"N Engl J Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1681\/ASN.2009080861","article-title":"Spontaneous remission of nephrotic syndrome in idiopathic membranous nephropathy","volume":"21","author":"Polanco","year":"2010","journal-title":"J Am Soc Nephrol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1681\/ASN.2013040430","article-title":"Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy","volume":"25","author":"Hoxha","year":"2014","journal-title":"J Am Soc Nephrol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1172\/JCI109987","article-title":"A new role for complement in experimental membranous nephropathy in rats","volume":"66","author":"Salant","year":"1980","journal-title":"J Clin Invest."},{"key":"B7","first-page":"185","article-title":"Depletion of C6 prevents development of proteinuria in experimental membranous nephropathy in rats","volume":"135","author":"Baker","year":"1989","journal-title":"Am J Pathol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1093\/ndt\/gfr534","article-title":"Absence of glomerular IgG4 deposition in patients with membranous nephropathy may indicate malignancy","volume":"27","author":"Qu","year":"2012","journal-title":"Nephrol Dial Transplant."},{"key":"B9","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/ckj\/sfv049","article-title":"Glomerular IgG subclasses in idiopathic and malignancy-associated membranous nephropathy","volume":"8","author":"L\u00f6nnbro-Widgren","year":"2015","journal-title":"Clin Kidney J."},{"key":"B10","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1093\/ndt\/gfg616","article-title":"Distribution of glomerular IgG subclass deposits in malignancy-associated membranous nephropathy","volume":"19","author":"Ohtani","year":"2004","journal-title":"Nephrol Dial Transplant."},{"key":"B11","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/ki.2012.209","article-title":"Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy","volume":"82","author":"Hoxha","year":"2012","journal-title":"Kidney Int."},{"key":"B12","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1681\/ASN.2016010050","article-title":"An indirect immunofluorescence method facilitates detection of thrombospondin type 1 domain-containing 7A-specific antibodies in membranous nephropathy","volume":"28","author":"Hoxha","year":"2017","journal-title":"J Am Soc Nephrol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/modpathol.2012.207","article-title":"Determination of primary versus secondary membranous glomerulopathy utilizing phospholipase A2 receptor staining in renal biopsies","volume":"26","author":"Larsen","year":"2013","journal-title":"Mod Pathol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1111\/ajt.13806","article-title":"Temporal IgG subtype changes in recurrent idiopathic membranous nephropathy","volume":"16","author":"Kattah","year":"2016","journal-title":"Am J Transplant."},{"key":"B15","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s10157-016-1235-2","article-title":"Circulating antibodies to alpha-enolase and phospholipase A2 receptor and composition of glomerular deposits in Japanese patients with primary or secondary membranous nephropathy","volume":"21","author":"Kimura","year":"2017","journal-title":"Clin Exp Nephrol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s40620-016-0268-7","article-title":"Membranous glomerulonephritis: histological and serological features to differentiate cancer-related and non-related forms","volume":"29","author":"Murtas","year":"2016","journal-title":"J Nephrol."},{"key":"B17","first-page":"145","article-title":"Pathology of membranous nephropathy","volume":"3","author":"Ehrenreich","year":"1968","journal-title":"Path Ann."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMc1511702","article-title":"A mechanism for cancer-associated membranous nephropathy","volume":"374","author":"Hoxha","year":"2016","journal-title":"N Engl J Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1172\/JCI72270","article-title":"Membranous nephropathy: from models to man","volume":"124","author":"Beck","year":"2014","journal-title":"J Clin Invest."},{"key":"B20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.7326\/0003-4819-64-1-41","article-title":"The association of cancer and the nephrotic syndrome","volume":"64","author":"Lee","year":"1966","journal-title":"Ann Intern Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12882-018-0828-2","article-title":"Quantification of cancer risk in glomerulonephritis","volume":"19","author":"Heaf","year":"2018","journal-title":"BMC Nephrol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1159\/000364782","article-title":"Prevalence of cancer in membranous nephropathy: a systematic review and meta-analysis of observational studies","volume":"40","author":"Leeaphorn","year":"2014","journal-title":"Am. J. Nephrol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ejmg.2017.10.014","article-title":"THSD7A-associated membranous nephropathy in a patient with neurofibromatosis type 1","volume":"61","author":"Lin","year":"2018","journal-title":"Eur J Med Genet."},{"key":"B24","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1056\/NEJMoa1009742","article-title":"Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy","volume":"364","author":"Stanescu","year":"2011","journal-title":"N Engl J Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1093\/ndt\/gfx296","article-title":"Genetics of membranous nephropathy","volume":"33","author":"Gupta","year":"2018","journal-title":"Nephrol. Dial. Transplant"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1681\/ASN.2017070805","article-title":"The most N-terminal region of THSD7A is the predominant target for autoimmunity in THSD7A-associated membranous nephropathy","volume":"29","author":"Seifert","year":"2018","journal-title":"J Am Soc Nephrol."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.03035\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,12,20]],"date-time":"2018-12-20T02:59:16Z","timestamp":1545274756000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fimmu.2018.03035\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,20]]},"references-count":26,"alternative-id":["10.3389\/fimmu.2018.03035"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2018.03035","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,20]]},"article-number":"3035"}}